Bone Biologics Corp (BBLGW) Total Non-Current Liabilities (2022 - 2025)
Bone Biologics (BBLGW) posted quarterly Total Non-Current Liabilities of $417884.0 for Q4 2025, up 12.02% year-over-year from $373042.0 in Q4 2024, and up 25.46% quarter-over-quarter from $333081.0 in Q3 2025.
Bone Biologics Corp (BBLGW) Total Non-Current Liabilities (2022 - 2025) Analysis & Trends
Bone Biologics (BBLGW) has reported Total Non-Current Liabilities for 4 consecutive years, with $417884.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Total Non-Current Liabilities rose 12.02% year-over-year to $417884.0; the TTM figure through Dec 2025 stood at $417884.0 (up 12.02% YoY), while the FY2025 annual figure was $417884.0, up 12.02% from the prior year.
- Total Non-Current Liabilities rose to $417884.0 in Q4 2025 per BBLGW's latest filing, from $333081.0 in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $2.3 million in Q1 2023 and bottomed at $146186.0 in Q1 2024.
- Historically, Total Non-Current Liabilities has averaged $706885.5 across 4 years, with a median of $403729.0 in 2025.
- Annual changes were most pronounced in 2024 — Total Non-Current Liabilities tumbled 93.59% — and 2025, when it jumped 69.54%.
- Bone Biologics' Total Non-Current Liabilities stood at $888461.0 in 2022, then decreased by 12.7% to $775651.0 in 2023, then slumped by 51.91% to $373042.0 in 2024, then climbed by 12.02% to $417884.0 in 2025.
- Business Quant data shows BBLGW's Total Non-Current Liabilities at $417884.0 in Q4 2025, $333081.0 in Q3 2025, and $403729.0 in Q2 2025.
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 417,884.00 |
| Sep 30, 2025 | 333,081.00 |
| Jun 30, 2025 | 403,729.00 |
| Mar 31, 2025 | 247,843.00 |
| Dec 31, 2024 | 373,042.00 |
| Sep 30, 2024 | 255,773.00 |
| Jun 30, 2024 | 276,852.00 |
| Mar 31, 2024 | 146,186.00 |
| Dec 31, 2023 | 775,651.00 |
| Sep 30, 2023 | 1.10 Mn |
| Jun 30, 2023 | 1.69 Mn |
| Mar 31, 2023 | 2.28 Mn |
| Dec 31, 2022 | 888,461.00 |